Coronary Artery Bypass Graft Procedures Market Size, Share - Growth Analysis Report and Forecast Trends (2026-2035)

The global coronary artery bypass graft procedures market was valued at USD 15.43 Billion in 2025. It is poised to grow at a CAGR of 9.40% during the forecast period of 2026-2035, and reach USD 37.89 Billion by 2035. The market growth is driven by the rising global burden of coronary artery disease, growing adoption of multiarterial and minimally invasive grafting techniques, expanding use of robotic and hybrid revascularization strategies, and increasing demand for durable conduit options across aging populations.

Latest News on the Coronary Artery Bypass Graft (CABG) Procedures Market (2026)

• In April 2026, MDPI's Journal of Clinical Medicine published a major review on the evolution of coronary revascularization, highlighting how AI-guided patient selection, robotic-assisted CABG, and hybrid revascularization strategies are reshaping treatment pathways for complex multi-vessel disease.
• In January 2026, Frontiers in Cardiovascular Medicine featured a comprehensive review on the LITA-LAD bypass, reaffirming that more than five decades after its introduction, the left internal thoracic artery to left anterior descending artery graft remains the cornerstone of CABG and continues to define excellence in cardiac surgery.
• In January 2025, Humacyte announced plans to file an IND with the U.S. FDA for first-in-human trials of its bioengineered ATEV graft for CABG procedures.

Key Market Trends and Insights

• Based on graft type, the saphenous vein segment is likely to dominate as it held above 62% market share in the historical period.
• Based on surgery type, the triple CABG procedures segment is likely to lead as it accounted for more than 30% market share in the historical period.
• Based on region, North America is expected to dominate as it accounted for about 37% market share in the historical period.

Market Size & Forecast

• Market Size (2025): USD 15.43 Billion
• Projected Market Size (2035): USD 37.89 Billion
• CAGR (2026-2035): 9.40%
• Largest Market in 2025: North America

Coronary Artery Bypass Graft Procedures Market Overview

The market reached a value of approximately USD 15.43 Billion in 2025. Steady expansion is expected over the forecast period, supported by the continued rise in ischemic heart disease prevalence and the gradual shift toward conduit-optimized, multiarterial grafting strategies. The demand for advanced surgical platforms, including robotic systems, off-pump stabilizers, and intraoperative graft flow assessment tools, is accelerating adoption. Integration with hybrid coronary revascularization pathways and the growing role of imaging-guided planning is reinforcing procedural quality. Additionally, expanding access in emerging economies and innovation in cardiovascular devices are expected to sustain long-term cardiac surgery expansion.

Coronary Artery Bypass Graft Procedures Market Segmentation

Market Breakup by Graft Type

• Saphenous Vein Grafts
• Internal Thoracic Artery Grafts
• Others

The market is segmented by graft type into saphenous vein grafts, internal thoracic artery grafts, and other arterial conduits, including the radial artery and right gastroepiploic artery. Saphenous vein grafts are likely to lead due to their widespread use, ease of harvesting, and suitability as supplementary conduits in multi-vessel coronary artery bypass procedures, while arterial grafts such as the left internal thoracic artery (LITA) to the left anterior descending (LAD) artery continue to demonstrate superior long-term patency and survival benefits.

Market Breakup by Surgery Type

• Single CABG Surgery
• Double CABG Surgery
• Triple CABG Surgery
• Quadruple CABG Surgery

Based on surgery type, the market is segmented into single, double, triple, and quadruple CABG procedures, reflecting the number of bypassed coronary vessels. Triple CABG is likely to dominate due to the high prevalence of multi-vessel disease in surgical candidates, while quadruple bypass procedures are typically reserved for patients with extensive coronary involvement. Procedural complexity drives demand for advanced perfusion, imaging, and stabilization systems.

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate due to advanced cardiac surgical infrastructure, high procedural volumes, and strong reimbursement frameworks, while Europe maintains steady growth supported by long-established surgical centers. Asia Pacific is expected to expand rapidly, supported by rising cardiovascular disease burden and improving access to specialist cardiac care.

Coronary Artery Bypass Graft Procedures Market Growth Analysis and Key Influencers

Analysis Type

Factors

Example

Market Drivers

Rising prevalence of coronary artery disease and ischemic heart conditions globally

Growing surgical volumes for multi-vessel disease, supporting demand for advanced grafting platforms

Market Restraints

Saphenous vein graft failure rates and competition from PCI in single-vessel disease

Late vein graft occlusion and the rise of drug-eluting stents reduce CABG referrals in lower-risk anatomy

Market Opportunities

Expansion of robotic-assisted, off-pump, and hybrid coronary revascularization procedures

Growing adoption of minimally invasive direct CABG and tissue-engineered conduits creating new growth avenues

Coronary Artery Bypass Graft Procedures Market Dynamics

This section analyzes the key factors influencing market growth, including disease burden, technology adoption, regulatory drivers, cost dynamics, and ecosystem shifts, while integrating interlinking keywords to highlight industry-wide connections.

Coronary Artery Bypass Graft Procedures Market Drivers

Rising Coronary Artery Disease Burden Driving Market Growth

The increasing global burden of coronary artery disease is a major driver of market expansion, supported by aging populations and rising prevalence of diabetes, hypertension, and metabolic syndrome. CABG remains the most commonly performed major cardiac operation worldwide, with nearly 400,000 procedures performed annually in the United States alone. The continuing shift toward multi-vessel grafting in patients with complex anatomy is sustaining surgical volumes, thereby driving growth in cardiac surgery instruments during the forecast period.

Coronary Artery Bypass Graft Procedures Market Restraints

Saphenous Vein Graft Failure and PCI Competition Limiting Market Penetration

Late saphenous vein graft failure due to atherosclerosis and intimal hyperplasia remains a major clinical and economic restraint, alongside competition from percutaneous coronary intervention (PCI) in single-vessel and lower-risk anatomy. The continued evolution of drug-eluting stents and physiology-guided lesion selection is shifting some patients toward catheter-based revascularization. However, advances in conduit preservation, no-touch vein harvesting, and intraoperative graft flow assessment are gradually improving CABG outcomes, supporting sustained growth across the cardiac surgery market during the forecast period.

Coronary Artery Bypass Graft Procedures Market Opportunities

Robotic and Hybrid Revascularization Creating Strong Opportunities

The growing adoption of robotic-assisted CABG and hybrid coronary revascularization strategies is creating significant growth opportunities, supported by improved patient recovery and shorter hospital stays. For instance, in April 2026, peer-reviewed clinical reviews highlighted how AI-guided patient selection, robotic platforms, and hybrid pathways combining CABG with PCI are tailoring revascularization to coronary anatomy and patient profile. These advances are expanding the addressable patient pool and supporting durable, less-invasive surgical robotics solutions across the CABG market.

Coronary Artery Bypass Graft Procedures Market Trends

Minimally Invasive CABG Techniques Shaping Emerging Market Advancement

The rapid evolution of minimally invasive and catheter-based coronary artery bypass graft procedures is emerging as a key trend in the market, driven by the need to reduce surgical trauma and improve patient outcomes. For instance, in January 2026, a research team from the National Heart, Lung, and Blood Institute (NIH) and Emory School of Medicine, alongside cardiologists, performed the first coronary artery bypass procedure without opening the chest. They used a catheter-based technique via the leg artery to conclude this procedure. This advancement significantly shortens recovery time and minimizes procedural risks compared to traditional open-heart surgery. Such innovations are reshaping surgical approaches, accelerating the shift toward less invasive revascularization strategies, and redefining clinical workflows across the CABG landscape.

Coronary Artery Bypass Graft Procedures Market Share

Saphenous V ein Grafts Likely to Dominate the Market Segment by Graft Type

Saphenous vein grafts are likely to dominate the market, accounting for about 45% share in the historical period, driven by their widespread use, ease of harvesting, and suitability for multi-vessel CABG procedures. Their role in improving cardiac surgery outcomes and procedural flexibility supports consistent demand. In contrast, arterial grafts such as the left internal thoracic artery (LITA) to the left anterior descending (LAD) artery demonstrate superior long-term patency and survival outcomes, while advancements in minimally invasive surgery and off-pump techniques enhance overall efficiency.

Coronary Artery Bypass Graft Procedures Market Regional Analysis

North America is likely to dominate the market as it accounted for about 38% share in the historical period, supported by advanced cardiac surgical infrastructure, high procedural volumes, and strong reimbursement frameworks. The region benefits from early adoption of robotic platforms and hybrid revascularization pathways, strengthening healthcare technology integration. Additionally, the presence of specialized cardiac centers and structured rehabilitation programs supports better cardiovascular treatment outcomes and sustained market growth during the forecast period.

Leading Players in the Coronary Artery Bypass Graft Procedures Market

Boston Scientific Corporation

Boston Scientific Corporation, headquartered in Marlborough, Massachusetts, United States, was established in 1979 and is a global leader in medical devices for cardiovascular, rhythm, and neuromodulation applications. Its portfolio supports cardiac surgery and structural heart procedures, contributing to the broader cardiovascular intervention segment through advanced delivery and imaging technologies.

Ethicon US, LLC.

Ethicon US, LLC., headquartered in Raritan, New Jersey, United States, is a Johnson & Johnson MedTech company founded in 1949 and is a leading provider of surgical sutures, energy devices, and wound closure products. Its portfolio is widely used across cardiac surgery for graft anastomosis and haemostasis, reinforcing its position in the surgical instruments and consumables segment.

MAQUET Holding B.V. & Co. KG

MAQUET Holding B.V. & Co. KG, headquartered in Rastatt, Germany, is part of the Getinge Group and operates across cardiopulmonary, surgical workflow, and intensive care segments. Its portfolio includes the VasoView endoscopic vessel harvesting system and off-pump stabilisers widely used in CABG, holding a strong position in the cardiac surgery instrumentation segment.

Genesee Biomedical Inc.

Genesee Biomedical Inc., headquartered in Denver, Colorado, United States, was founded in 1991 and specializes in cardiac surgery instruments and retraction systems. Its portfolio includes a comprehensive range of internal thoracic artery retractors and CABG instrument sets used in open and minimally invasive bypass procedures, supporting its niche position within the cardiac surgical accessories segment.

Other key players in the market include KARL STORZ GmbH & Co. KG and many more.

Key Questions Answered in the Market Report

• What was the coronary artery bypass graft procedures market value in 2025?
• What is the coronary artery bypass graft procedures market forecast outlook for 2026-2035?
• What major factors aid the demand for the coronary artery bypass graft procedures market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major coronary artery bypass graft procedures market trends?
• Which graft type is expected to dominate the market segment?
• Which surgery type is expected to dominate the market segment?
• Who are the key players in the coronary artery bypass graft procedures market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?